Cost and effectiveness of non-penetrating deep sclerectomy ...
Cost and effectiveness of non-penetrating deep sclerectomy ...
Cost and effectiveness of non-penetrating deep sclerectomy ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
SUBJECT INDEX (KEYWORDS) | ÍNDICE POR ASSUNTO (DESCRITORES)<br />
A<br />
Aberrometry, 410<br />
Acquired immunodeficiency syndrome, 130<br />
Actinomyces<br />
isolation & purification, 441<br />
Adenocarcinoma, sebaceous, 365<br />
Adenovirus infections, human, 417<br />
diagnosis, 417<br />
Adenoviruses, human<br />
isolation & purification, 417<br />
Adrenal cortex hormones, 452<br />
therapeutic use, 132<br />
Adult, 286, 296, 365, 441<br />
Aged, 53, 441, 444<br />
Aged, 80 <strong>and</strong> over, 127<br />
Air pollutants<br />
adverse effects, 377<br />
Air pollution, 377<br />
Alopecia<br />
diagnosis, 55<br />
drug therapy, 55<br />
genetics, 55<br />
Amblyopia, 267<br />
Amnion<br />
transplantation, 55<br />
Amniotic membrane, 114<br />
Amyloidosis, 286, 374<br />
Angi<strong>of</strong>luoresceinography, 371<br />
Angiogenesis inhibitors, 338<br />
Angiogenesis inhibitors<br />
administration & dosage, 48<br />
therapeutic use, 371<br />
Animals, 352<br />
Anophthalmia<br />
surgery, 425<br />
Anophthalmos, 365<br />
complications, 357<br />
psychology, 330<br />
surgery, 357<br />
Anti-angiogenic drugs, 143<br />
Antibodies, monoclonal, 338<br />
administration & dosage, 214, 352<br />
adverse effects, 214<br />
therapeutic use, 289<br />
Aqueous humor, 201, 258<br />
Arthritis, rheumatoid<br />
complications, 132<br />
Astigmatism<br />
drug therapy, 414<br />
Autoantibodies, 405<br />
Behçet syndrome<br />
diagnosis, 395<br />
B<br />
V. 74 - 2011<br />
Beta particles, 300<br />
Beta-galactosidase<br />
metabolism, 430<br />
Biological factors, 33<br />
Biomechanics<br />
physiology, 13<br />
Biometry, 85<br />
Blepharitis, 422<br />
Blepharoptosis<br />
surgery, 211<br />
Blepharospasm<br />
drug therapy, 414<br />
Blindness, 279<br />
etiology, 136<br />
prevention & control, 217, 323<br />
Blood flow velocity, 326<br />
physiology 361<br />
Botulinum toxins, type A<br />
therapeutic use, 414<br />
Brazil 323<br />
Burns, chemical, 48<br />
C<br />
Canada<br />
epidemiology, 21<br />
Carcinoma in situ, 21<br />
Carcinoma, basal cell<br />
diagnosis, 245<br />
epidemiology, 245<br />
Carcinoma, squamous cell, 21<br />
Case reports, 53, 58, 61, 127, 130, 132, 134, 207, 209, 211,<br />
214, 286, 292, 296, 365, 368, 371, 374, 441, 444, 447, 449<br />
Cataract, 163, 323<br />
classification, 110<br />
congenital, 85, 136, 271<br />
therapy, 271<br />
Cataract extraction, 166, 323<br />
Cavernous sinus, 130<br />
Cefazolin<br />
therapeutic use, 441<br />
Cell adhesion, 114<br />
Cell culture techniques, 114<br />
Central nervous system, 130<br />
Cerebrospinal fluid, 58<br />
Child, 163, 209, 211, 255, 271, 292<br />
Childhood development, 262<br />
Choroid<br />
blood supply, 395<br />
Choroid diseases<br />
drug therapy, 352<br />
Choroidal neovascularization, 289, 338, 371<br />
Chromosomes, human, X, 55<br />
Chronic disease, 326<br />
Cicatrix<br />
prevention & control, 283<br />
Climate, 377<br />
Clinical protocols, 175<br />
Collagen, 67<br />
Comparative study, 114, 123<br />
Conjunctiva, 377<br />
pathology, 21, 64<br />
transplantation, 123<br />
Conjunctival diseases<br />
pathology, 123<br />
Conjunctival neoplasms<br />
epidemiology, 21<br />
Conjunctivitis, 64<br />
diagnosis, 417<br />
Conjunctivis, allergic, 452<br />
Conjunctivitis, viral, 417<br />
Consensus, 452<br />
Cornea, 67, 97, 161, 377, 410<br />
anatomy & histology, 85<br />
cytology, 114<br />
pathology, 118, 286, 430<br />
physiology, 13<br />
physiopathology, 184<br />
surgery, 127<br />
Corneal diseases, 13, 17, 64<br />
pathology, 21<br />
surgery, 127<br />
Corneal dystrophies, hereditary, 118, 286<br />
Corneal edema, 195<br />
Corneal endothelial cell loss, 195<br />
Corneal neovascularization, 48<br />
Corneal opacity, 430, 447<br />
Corneal stroma<br />
surgery, 410<br />
Corneal topography, 85, 102, 161, 410<br />
Corneal transplantation, 17, 195<br />
methods, 435<br />
Corneal ulcer, 132<br />
<strong>Cost</strong>s, 400<br />
Cross-linking reagents<br />
therapeutic use, 348<br />
Cross-sectional studies, 110, 245<br />
Crystallins<br />
genetics, 136<br />
Curettage, 441<br />
Cytological techniques, 248<br />
Dacryiocystitis<br />
diagnosis, 441<br />
microbiology, 441<br />
D<br />
Arq Bras Oftalmol. 2011;74(6):463-74<br />
467
Change language